Oil prices have passed the $100 per barrel mark during Monday trading in Asia and Europe, as the war in Iran enters its 10th day. Both global crude benchmarks, Brent and West Texas Intermediate (WTI), ...

Okta Inc (NASDAQ: OKTA) on Wednesday reported upbeat fourth-quarter financial results, but issued weak forecast for the first quarter. Okta posted revenue of $761 million for the fourth quarter, ...

A group of Senate Democrats introduced a bill to exempt home construction materials from tariffs, a move the National Association of Home Builders has pushed for. S. 3943 would automatically exempt a ...

Russian and Iranian oil producers are offering deepening discounts as they compete for the same limited group of Chinese buyers after India retreated from purchases. India’s imports from Russia could ...

Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...

Novo Nordisk A/S (NYSE: NVO) announced plans on Tuesday to cut the list prices of its GLP-1 drugs by up to 50% in the U.S. starting in 2027. The price reduction will affect the obesity injection ...

The list prices of GLP-1 medications like Wegovy and Ozempic are set to fall by up to 50 percent next year following an announcement by pharmaceutical giant Novo ...

Novo Nordisk said Tuesday it will slash its prices for Wegovy and Ozempic beginning next year by up to 50%, highlighting the growing competition among pharmaceutical firms for customers seeking weight ...

Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027. The move aims to make the treatments more ...

Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and ...

FILE PHOTO: Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams/File Photo Feb 24 (Reuters) - Danish ‌drugmaker Novo ‌Nordisk ...